Description: PainReform Ltd. operates as a pharmaceutical company. It develops and markets pharmaceuticals. The firm focuses on developing reformulation of pain therapeutics, PainReform applies its propriety formulation technologies to prolong and enhance efficacy, reduce adverse effects shortening recovery time and reduce the need of augmentation with drugs such as opioids and NSAIDS. The company was founded by Lihu Avitov and Dan Teleman in 2007 and is headquartered in Herzliya, Israel.
Home Page: www.painreform.com
PRFX Technical Analysis
65 Yigal Alon Street
Tel Aviv,
6745442
Israel
Phone:
972 3 717 7050
Officers
| Name | Title |
|---|---|
| Dr. Ehud Geller Ph.D. | Exec. Chairman |
| Mr. Ilan Hadar M.B.A., MBA | CEO & CFO |
| Dr. Sigal Aviel | Chief Operating Officer |
| Prof. Eli Hazum Ph.D. | CTO & Director |
| Dr. Stephen A. Cooper D.M.D Ph.D. | Exec. VP of Devel. |
Exchange: NASDAQ
Country: US
Currency: US Dollar ($)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 0.4583 |
| Price-to-Sales TTM: | 0 |
| IPO Date: | 2020-09-01 |
| Fiscal Year End: | December |
| Full Time Employees: | 4 |